Document is current
Any future updates will be listed below
-
Authors
Naranjo, Antonio https://orcid.org/0000-0002-2013-6664
Sarmiento, Cristian
Molina, Amparo
Fuentes, Sonia
Cáceres, Laura
Ojeda, Soledad
-
Funding
Funding for this research was provided by:
Universidad de las Palmas de Gran Canaria
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 15 February 2025
First Online: 7 March 2025
Declarations
:
: This study was approved by an ethics and research committee with the code NAR-OST-2011–02.
: Antonio Naranjo has received support for registration and travel to congresses provided by Amgen Eu-ropa and Alfasigma SpA and fees from Amgen Europa GmbH and UCB for conferences. Soledad Ojeda has received support for registration and travel to congresses provided by Amgen Europe and honoraria for speaking engagements from Amgen Europa GmbH and UCB. Laura Cáceres has received support for registration and travel to congresses provided by Amgen Europe and honoraria for speaking engagements from Amgen Europa GmbH. Cristian Sarmiento and Amparo Molina declare that they have no conflict of interest.
